Paul Jean Valles - Director, Pfizer Inc
As of April 29, 2005
What is Paul Jean Valles's Net Worth?
The current estimated net worth of Pfizer Inc's Director, Paul Jean Valles, is estimated to be about $59.79M . Paul Jean Valles owns about 784,174 units of Pfizer Inc common stock. In the last 2 years at Pfizer Inc, Paul Jean Valles has sold an estimated value of $2.83M worth.
What is Paul Jean Valles's Past Insider Trading?
Paul Jean Valles's largest sale order was 100,000 units , worth over $2.83M on December 2, 2004. In total, Paul Jean Valles has made about 11 transactions over 2 years of their time at Pfizer Inc. Paul Jean Valles usually trades in January, April and September, with the busiest year in 2004.
PAUL JEAN VALLES
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Paul Jean Valles's' Mailing Address?
- Mailing address is 78 Middle Patent Road Bedford NY 10506 NY
Pfizer Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|---|
| A. Bourla | 2020 | $1,650,000 | - | $4,897,817 | $6,782,951 | $5,491,800 | $1,367,780 | $843,222 | $21,033,570 |
| A. Bourla | 2019 | $1,600,000 | - | $4,290,956 | $6,075,290 | $3,630,000 | $1,726,448 | $606,269 | $17,928,963 |
| A. Bourla | 2018 | $1,400,000 | - | $2,592,079 | $3,954,369 | $1,533,000 | $0 | $375,109 | $9,854,557 |
| F. D’Amelio | 2020 | $1,533,750 | - | $2,406,437 | $3,130,596 | $2,470,000 | $1,318,297 | $517,016 | $11,376,096 |
| F. D’Amelio | 2019 | $1,500,000 | - | $2,582,446 | $3,037,649 | $1,820,000 | $1,612,163 | $523,472 | $11,075,730 |
| F. D’Amelio | 2018 | $1,407,917 | - | $2,013,091 | $2,108,995 | $1,310,000 | $0 | $299,826 | $7,139,829 |
| M. Dolsten | 2020 | $1,433,750 | - | $2,110,585 | $2,608,832 | $2,600,000 | $928,638 | $467,819 | $10,149,624 |
| M. Dolsten | 2019 | $1,400,000 | - | $2,414,725 | $2,531,376 | $1,820,000 | $987,243 | $444,701 | $9,598,045 |
| M. Dolsten | 2018 | $1,306,250 | - | $2,013,091 | $2,108,995 | $1,326,000 | $0 | $315,863 | $7,070,199 |
| A. Hwang | 2020 | $1,142,500 | - | $1,420,129 | $2,087,062 | $2,387,800 | $405,242 | $440,714 | $7,883,447 |
| J. Young | 2020 | $1,285,000 | - | $1,814,734 | $2,087,062 | $1,800,000 | $1,551,403 | $450,994 | $8,989,193 |
| J. Young | 2019 | $1,245,000 | - | $2,247,004 | $2,025,093 | $1,675,000 | $1,325,847 | $441,439 | $8,959,383 |
| J. Young | 2018 | $1,206,250 | - | $2,013,091 | $2,108,995 | $1,385,000 | $0 | $408,379 | $7,121,715 |
| No matching records found | |||||||||
Source: https://www.sec.gov/Archives/edgar/data/78003/000007800321000047/proxystatement.htm
What are Pfizer Inc's Past Insider Trades?
Pfizer Inc's most recent insider trade came on June 8, 2022 by Jennifer B Damico who sold 4,218 units worth $227.6K . In the last 19 years, insiders at Pfizer Inc have sold an estimated value of $956.55M and bought an estimated value of $479.03M worth of shares. Insider trading is most common in April, with the busiest year in 2013. The most active traders at the company are Loretta V Cangialosi, Sr. Vice President, Ian C Read, Executive Chairman, and Albert Bourla, Chairman & CEO .
PFIZER INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||